Acne pill benefits outweigh blood clot risk: EU agency

accreditation
0:00
play article
Subscribers can listen to this article
iStock

Europe's medicines watchdog said Friday the benefits of acne drug Diane 35, widely used as a contraceptive, outweigh the risk of developing blood clots in the veins.

The clot risk was "low", said a European Medicines Agency (EMA) ruling on a French-initiated review of the drug's safety. But it stressed Diane 35 should only be used when alternative acne treatments had failed.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24